Diagnostics
Total Isolation of CTCs & Lossless Staining For Complete Analyses With One-Touch Automation
CTCeptor
The CTCeptor, a trailblazer in cancer diagnostics, is the world's first fully automated system that isolates every circulating tumor cell (CTC) using innovative Continuous Centrifugal Microfluidics technology. This revolutionizes the separation of rare cells. Complemented by our HyPICC technology, which significantly reduces cell loss during staining, the CTCeptor facilitates exceptionally accurate single-cell selection. This capability is crucial for advanced, personalized Multi-omics diagnostics, offering a new dimension in targeted cancer treatment strategies.
How It Works
Core Technology
CCM
Continuous Centrifugal Microfluidics allows total isolation of circulating tumor cells
CTC Staining
Hydrogel Pellicle for Lossless Immunocytochemistry (HyPICC) exhibits over 97% retention rate
CCM Technology
CTCELLS' circulating tumor cell isolation instrument is powered by continuous centrifugal microfluidics. It is the world’s 1st technology that is fully automated and capable of total isolation of circulating tumor cells. Our cutting-edge technology shifts from the usual positive selection to a negative selection method. By selectively removing all blood cells, it totally isolates circulating tumor cells, enhancing the precision of subsequent analyses and research.
Hydrogel Pellicle ICC Technology (HyPlCC)
HyPICC employs a thin, permeable hydrogel layer to encase cells, allowing vital nutrients and signals to permeate without obstruction. Its semi-porous structure also guards against cell loss, safeguarding sample integrity during analysis. HyPICC sets a new benchmark in preserving cell health and accuracy, heralding advances in cell research and diagnostics.